...
首页> 外文期刊>British Journal of Haematology >Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes
【24h】

Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes

机译:三元素8作为一种异常异常的预后价值及额外细胞遗传学畸变对原发性髓细胞增强症的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Trisomy 8 is the most common chromosomal gain in myelodysplastic syndromes (MDS), however, little is known about the features of MDS with isolated trisomy 8 and the influence of additional cytogenetic aberrations. We determined the characteristics and prognostic factors of 72 patients with trisomy 8 as a single anomaly and analysed also the impact of other aberrations added to trisomy 8 in another 62 patients. According to our study, MDS with isolated trisomy 8 was more frequent in men, with more than one cytopenia in most patients (62%) and having about 4% bone marrow blasts. The multivariate analysis demonstrated that platelet count and percentage bone marrow blasts had the strongest impact on overall survival (OS). The median OS for isolated trisomy 8, trisomy 8 plus one aberration (tr8 + 1), plus two (tr8 + 2) and plus three or more aberrations (tr8 + ≥3) was 34·3, 40, 23·4 and 5·8 months, respectively (P < 0·001). Trisomy 8 confers a poorer prognosis than a normal karyotype in MDS patients with ≥5% bone marrow blasts. This study supports the view that MDS with isolated trisomy 8 should be included in the intermediate cytogenetic risk group.
机译:Trisomy 8是Myelodysplastic综合征(MDS)中最常见的染色体增益,但是关于MDS的特征与分离的三元体8的特征很少,以及额外的细胞遗传学畸变的影响。我们确定了72例三元素8患者作为单一异常的特点和预后因素,并分析了另外62例患者在三兆癣中的影响。根据我们的研究,MDS与孤立的三术8中的MDS在男性中更频繁,大多数患者(62%)和大约4%的骨髓爆炸中有多于一种细胞脑。多变量分析表明,血小板计数和骨髓爆炸百分比对整体存活率的最强烈影响(OS)。用于隔离三元素8的中位操作系统,三元8加上一个像差(TR8 + 1),加上两个(TR8 + 2)和加三个或更多像差(TR8 +≥3)为34·3,40,23·4和5 ·分别为8个月(P <0·001)。三元8赋予较差的预后,而不是MDS患者≥5%骨髓爆炸的正常核型。本研究支持与孤立的三元素8的MDS应包括在中间细胞遗传学风险组中的视图。

著录项

  • 来源
    《British Journal of Haematology》 |2012年第3期|共11页
  • 作者单位

    Laboratori de Citologia Hematològica Laboratori de Citogenètica Molecular Serveis de Patologia i;

    Laboratori de Citologia Hematològica Laboratori de Citogenètica Molecular Serveis de Patologia i;

    Servicio de Hematología Hospital Universitario Central de Asturias Oviedo Spain;

    Servicio de Hematología Hospital Universitario Central de Asturias Oviedo Spain;

    Servicio de Hematología Hospital Universitario de Salamanca Salamanca Spain;

    Servicio de Hematología Hospital Universitario de Salamanca Salamanca Spain;

    Servicio de Hematología Hospital Universitario La Fe Valencia Spain;

    Servei d'Hematología Hospital Universitari Arnau de Vilanova Lleida Spain;

    Servicio de Hematología Hospital General de Valencia Valencia Spain;

    Servicio de Hematología Hospital General de Valencia Valencia Spain;

    Laboratori de Citologia Hematològica Laboratori de Citogenètica Molecular Serveis de Patologia i;

    Laboratori de Citologia Hematològica Laboratori de Citogenètica Molecular Serveis de Patologia i;

    Servicio de Hematología Hospital Son Llàtzer Mallorca Spain;

    Servei d'Hematología Hospital Clínic Barcelona Barcelona Spain;

    Servei d'Hematología Hospital Universitari Germans Trias i Pujol Badalona Spain;

    Servei d'Hematología Hospital Vall d'Hebron Barcelona Spain;

    Servicio de Hematología Hospital Universitario de Canarias La Laguna-Tenerife Spain;

    Servicio de Hematología Hospital Universitario La Fe Valencia Spain;

    Servicio de Hematología Hospital Universitario La Fe Valencia Spain;

    Laboratori de Citologia Hematològica Laboratori de Citogenètica Molecular Serveis de Patologia i;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 血液及淋巴系疾病;
  • 关键词

    Cytogenetic aberrations; Myelodysplastic syndromes; Trisomy 8;

    机译:细胞遗传学畸变;骨髓增生症综合征;三重子8;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号